有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2S)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)propanehydrazide | —— | C12H16N2O3S |
|
—— | 4-[[(2R)-oxolan-2-yl]methyl]-3-prop-2-enylsulfanyl-5-thiophen-2-yl-1,2,4-triazole | —— | C14H17N3OS2 |
|
—— | 3-methylsulfanyl-4-[[(2R)-oxolan-2-yl]methyl]-5-thiophen-2-yl-1,2,4-triazole | —— | C12H15N3OS2 |
|
—— | N-[(1R,2R)-2-methylcyclohexyl]-2-phenylsulfanylpyridine-3-carboxamide | —— | C19H22N2OS |
|
—— | N-[(1S,2R)-2-methylcyclohexyl]-2-phenylsulfanylpyridine-3-carboxamide | —— | C19H22N2OS |
|
—— | N-[(1S,2S)-2-methylcyclohexyl]-2-phenylsulfanylpyridine-3-carboxamide | —— | C19H22N2OS |
|
—— | (2R)-N-(cyclohexylmethyl)-2-pyridin-2-ylsulfanylpropanamide | —— | C15H22N2OS |
|
—— | (2R)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)propanehydrazide | —— | C12H16N2O3S |
|
—— | 2-ethylsulfanyl-N-[(1S)-1-(2-fluorophenyl)ethyl]aniline | —— | C16H18FNS |
|
—— | N-[(1R,2S)-2-methylcyclohexyl]-2-phenylsulfanylpyridine-3-carboxamide | —— | C19H22N2OS |
|
—— | (2S,6S)-2,6-dimethyl-4-(4-phenylsulfanylbutyl)morpholin-4-ium | —— | C16H26NOS+ |
|
—— | 4-[2-(2-Phenylsulfanylethoxy)ethyl]morpholin-4-ium | —— | C14H22NO2S+ |
|
—— | (2S,6S)-2,6-dimethyl-4-(4-phenylsulfanylbutyl)morpholine | —— | C16H25NOS |
|
—— | 1-Methyl-4-[2-(2-phenylsulfanylethoxy)ethyl]piperazine-1,4-diium | —— | C15H26N2OS+2 |
|
—— | 1-Methyl-4-[2-(4-methylphenyl)sulfanylethyl]piperazine-1,4-diium | —— | C14H24N2S+2 |
|
—— | 1-Methyl-4-(3-phenylsulfanylpropyl)piperazine-1,4-diium | —— | C14H24N2S+2 |
|
—— | (2R,6R)-2,6-dimethyl-4-(4-phenylsulfanylbutyl)morpholin-4-ium | —— | C16H26NOS+ |
|
—— | (2R,6S)-2,6-dimethyl-4-(4-phenylsulfanylbutyl)morpholine | —— | C16H25NOS |
|
—— | (S)-[4-methyl-5-[(5-phenyl-1,3,4-oxadiazol-2-yl)methylsulfanyl]-1,2,4-triazol-3-yl]-phenylmethanol | —— | C19H17N5O2S |
|
—— | 4-Methyl-1-[2-(2-phenylsulfanylethoxy)ethyl]piperidin-1-ium | —— | C16H26NOS+ |
|
—— | (2R,6R)-2,6-dimethyl-4-(4-phenylsulfanylbutyl)morpholine | —— | C16H25NOS |
|
—— | 1-Methyl-4-[3-(4-methylphenyl)sulfanylpropyl]piperazine-1,4-diium | —— | C15H26N2S+2 |
|
—— | N-[(2R)-2-(dimethylamino)-2-(furan-2-yl)ethyl]-2-(3,4-dimethylphenyl)sulfanylpyridine-3-carboxamide | —— | C22H25N3O2S |
|
—— | 2-(4-bromophenyl)sulfanyl-N-[(2R)-2-(dimethylamino)-2-(furan-2-yl)ethyl]pyridine-3-carboxamide | —— | C20H20BrN3O2S |
|
—— | N-[(2S)-2-(dimethylamino)-2-(furan-2-yl)ethyl]-2-(2,4-dimethylphenyl)sulfanylpyridine-3-carboxamide | —— | C22H25N3O2S |
|
—— | 2-(4-bromophenyl)sulfanyl-N-[(2S)-2-(dimethylamino)-2-(furan-2-yl)ethyl]pyridine-3-carboxamide | —— | C20H20BrN3O2S |
|
—— | 2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(2S)-2-(dimethylamino)-2-(furan-2-yl)ethyl]acetamide | —— | C18H19ClN4O3S |
|
—— | 2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(2R)-2-(dimethylamino)-2-(furan-2-yl)ethyl]acetamide | —— | C18H19ClN4O3S |
|
—— | N-[(2R)-2-(dimethylamino)-2-(furan-2-yl)ethyl]-2-(2,4-dimethylphenyl)sulfanylpyridine-3-carboxamide | —— | C22H25N3O2S |
|
—— | 3-(2-chlorophenyl)sulfanyl-N-[(2S)-2-(furan-2-yl)-2-piperidin-1-ylethyl]propanamide | —— | C20H25ClN2O2S |
|
—— | 3-(2-chlorophenyl)sulfanyl-N-[(2R)-2-(furan-2-yl)-2-piperidin-1-ylethyl]propanamide | —— | C20H25ClN2O2S |
|
—— | 2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[(2S)-2-(furan-2-yl)-2-piperidin-1-ylethyl]acetamide | —— | C21H27N5O2S2 |
|
—— | N-[(1R,2R,3S)-2,3-dimethylcyclohexyl]-2-[(4-methyl-6-oxo-1H-pyrimidin-2-yl)sulfanyl]acetamide | —— | C15H23N3O2S |
|
—— | N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]-2-[(4-methyl-6-oxo-1H-pyrimidin-2-yl)sulfanyl]acetamide | —— | C15H23N3O2S |
|
—— | [2-[(2S)-2-ethylpiperidin-1-yl]-2-oxoethyl] 2-(2-cyanophenyl)sulfanylbenzoate | —— | C23H24N2O3S |
|
—— | (4R)-2,6-dimethyl-4-(4-methylsulfanylphenyl)-3,4-dihydropyridine-3,5-dicarbonitrile | —— | C16H15N3S |
|
—— | 2-(4-bromo-2,5-dimethylphenyl)sulfanyl-N-[(Z)-[(2R)-2-methylcyclohexylidene]amino]acetamide | —— | C17H23BrN2OS |
|
—— | N-[(2R)-butan-2-yl]-2-[[5-(2-methylfuran-3-yl)-4-[(1R)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C21H26N4O2S |
|
—— | N-(furan-2-ylmethyl)-2-[[5-(2-methylfuran-3-yl)-4-[[(2S)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C19H22N4O4S |
|
—— | N-[(1R,2R)-2-methylcyclohexyl]-2-[[5-(2-methylfuran-3-yl)-4-[[(2S)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C21H30N4O3S |
|
—— | N-[(1S,2R)-2-methylcyclohexyl]-2-[[4-methyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C17H24N4O2S |
|
—— | N-[(1R,2R)-2-methylcyclohexyl]-2-[[4-methyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C17H24N4O2S |
|
—— | 2-[[4-(furan-2-ylmethyl)-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(1S,2S)-2-methylcyclohexyl]acetamide | —— | C21H26N4O3S |
|
—— | 2-[[4-ethyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide | —— | C18H26N4O2S |
|
—— | 2-[[4-benzyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(2R)-butan-2-yl]acetamide | —— | C20H24N4O2S |
|
—— | 1-[2-[[5-(Furan-2-yl)-4-(2-methoxyethyl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]piperidin-1-ium | —— | C16H25N4O2S+ |
|
—— | 2-[[5-(2-methylfuran-3-yl)-4-[(1S)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]-1-morpholin-4-ylethanone | —— | C21H24N4O3S |
|
—— | 2-[[5-(2-methylfuran-3-yl)-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]-N-(thiophen-2-ylmethyl)acetamide | —— | C19H22N4O3S2 |
|
—— | 2-[[4-(furan-2-ylmethyl)-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(1S,2R)-2-methylcyclohexyl]acetamide | —— | C21H26N4O3S |
|
—— | 2-[[5-(2-methylfuran-3-yl)-4-[(1R)-1-phenylethyl]-1,2,4-triazol-3-yl]sulfanyl]-1-morpholin-4-ylethanone | —— | C21H24N4O3S |
|